Bone Biologics (BBLG) Accumulated Expenses (2010 - 2021)
Bone Biologics (BBLG) posted quarterly Accumulated Expenses of $297500.0 for Q4 2021, up 17.82% year-over-year from $252500.0 in Q4 2020, and down 85.43% quarter-over-quarter from $2.0 million in Q3 2021.
Powered by 
Analysis
Bone Biologics (BBLG) Accumulated Expenses (2010 - 2021) Analysis & Trends
Bone Biologics (BBLG) has reported Accumulated Expenses for 12 consecutive years, with $297500.0 the latest figure, recorded in Q4 2021.
- In Q4 2021, Accumulated Expenses rose 17.82% year-over-year to $297500.0; the TTM figure through Dec 2021 stood at $297500.0 (up 17.82% YoY), while the FY2021 annual figure was $297500.0, up 17.82% from the prior year.
- Accumulated Expenses slipped to $297500.0 in Q4 2021 per BBLG's latest filing, from $2.0 million in the prior quarter.
- Across five years, Accumulated Expenses topped out at $2.0 million in Q3 2021 and bottomed at $62225.0 in Q2 2018.
- Historically, Accumulated Expenses has averaged $435574.0 across 5 years, with a median of $253025.5 in 2019.
- Annual changes were most pronounced in 2017 — Accumulated Expenses surged 10073.92% — and 2018, when it plunged 84.21%.
- Bone Biologics' Accumulated Expenses stood at $456000.0 in 2017, then slumped by 84.21% to $72017.0 in 2018, then surged by 252.07% to $253551.0 in 2019, then retreated by 0.41% to $252500.0 in 2020, then grew by 17.82% to $297500.0 in 2021.
- Business Quant data shows BBLG's Accumulated Expenses at $297500.0 in Q4 2021, $2.0 million in Q3 2021, and $1.8 million in Q2 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn |
| 10 | Bone Biologics | 1.00 Mn | 1.00 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2021 | 2.05 Mn |
| Sep 30, 2021 | 2.04 Mn |
| Jun 30, 2021 | 1.76 Mn |
| Mar 31, 2021 | 1.50 Mn |
| Dec 31, 2020 | 1.25 Mn |
| Sep 30, 2020 | 1.00 Mn |
| Jun 30, 2020 | 756,122.00 |
| Mar 31, 2020 | 508,801.00 |
| Dec 31, 2019 | 253,551.00 |
| Sep 30, 2019 | 177,500.00 |
| Jun 30, 2019 | 162,500.00 |
| Mar 31, 2019 | 491,667.00 |
| Dec 31, 2018 | 441,667.00 |
| Sep 30, 2018 | 391,667.00 |
| Jun 30, 2018 | 341,667.00 |
| Mar 31, 2018 | 291,667.00 |
| Dec 31, 2017 | 456,000.00 |
| Sep 30, 2017 | 191,667.00 |
| Jun 30, 2017 | 141,667.00 |
| Mar 31, 2017 | 91,667.00 |